Back

Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Lipid management and outcome Lipid-Lowering Agents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)

6 More presentations in this session

Presentation thumbnail
Professor A. Her (Chuncheon, KR)
Abstract
Presentation thumbnail
Assistant Professor J. Dopheide (Thun, CH)
Abstract Slides
Presentation thumbnail
Doctor C. Ballantyne (Houston, US)
Abstract Slides
Presentation thumbnail
Doctor E. Fountas (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor T. Konishi (Sapporo, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Lipid management and outcome

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
New trial evidence in the field of lipid management
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources